Trader consensus assigns a 78% implied probability to "No," driven by the CDC's ongoing absence of any Level 4 "Avoid All Travel" Travel Health Notices—the highest tier reserved for destinations posing extreme, life-threatening health risks—and no active Level 3 alerts either. Recent developments, including the March 2026 expansion of the Level 2 Global Polio notice to countries like Laos and Namibia amid circulating poliovirus, have not prompted escalation, as epidemiological data shows vaccination efforts containing spread without widespread paralysis cases. CDC public health risk assessments for avian influenza A(H5N1) remain low, lacking evidence of sustained human-to-human transmission. With seven months until resolution, traders eye weekly CDC surveillance updates and WHO reports for potential shifts from novel pathogens, though historical rarity of Level 4 issuances reinforces the current positioning.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
Sí
$71,397 Vol.
$71,397 Vol.
31 dic 2026
Sí
$71,397 Vol.
$71,397 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus assigns a 78% implied probability to "No," driven by the CDC's ongoing absence of any Level 4 "Avoid All Travel" Travel Health Notices—the highest tier reserved for destinations posing extreme, life-threatening health risks—and no active Level 3 alerts either. Recent developments, including the March 2026 expansion of the Level 2 Global Polio notice to countries like Laos and Namibia amid circulating poliovirus, have not prompted escalation, as epidemiological data shows vaccination efforts containing spread without widespread paralysis cases. CDC public health risk assessments for avian influenza A(H5N1) remain low, lacking evidence of sustained human-to-human transmission. With seven months until resolution, traders eye weekly CDC surveillance updates and WHO reports for potential shifts from novel pathogens, though historical rarity of Level 4 issuances reinforces the current positioning.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado abierto: Jan 19, 2026, 3:15 PM ET
Volumen
$71,397Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus assigns a 78% implied probability to "No," driven by the CDC's ongoing absence of any Level 4 "Avoid All Travel" Travel Health Notices—the highest tier reserved for destinations posing extreme, life-threatening health risks—and no active Level 3 alerts either. Recent developments, including the March 2026 expansion of the Level 2 Global Polio notice to countries like Laos and Namibia amid circulating poliovirus, have not prompted escalation, as epidemiological data shows vaccination efforts containing spread without widespread paralysis cases. CDC public health risk assessments for avian influenza A(H5N1) remain low, lacking evidence of sustained human-to-human transmission. With seven months until resolution, traders eye weekly CDC surveillance updates and WHO reports for potential shifts from novel pathogens, though historical rarity of Level 4 issuances reinforces the current positioning.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volumen
$71,397Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus assigns a 78% implied probability to "No," driven by the CDC's ongoing absence of any Level 4 "Avoid All Travel" Travel Health Notices—the highest tier reserved for destinations posing extreme, life-threatening health risks—and no active Level 3 alerts either. Recent developments, including the March 2026 expansion of the Level 2 Global Polio notice to countries like Laos and Namibia amid circulating poliovirus, have not prompted escalation, as epidemiological data shows vaccination efforts containing spread without widespread paralysis cases. CDC public health risk assessments for avian influenza A(H5N1) remain low, lacking evidence of sustained human-to-human transmission. With seven months until resolution, traders eye weekly CDC surveillance updates and WHO reports for potential shifts from novel pathogens, though historical rarity of Level 4 issuances reinforces the current positioning.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes